Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
startups
2
×
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
angellist
antibiotics
axial spondyloarthritis
bausch health
billing
biogen
biotech
boston blog main
boston top stories
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
clinical trials
cluster headache
crispr
deals
detroit blog main
detroit top stories
diagnostics
digital health
dihydroergotamine
dimitry nuyten
drug prices
eddingpharm
eli lilly
eligible
elizabeth holmes
What
road
2
×
approval
billing
billion
bio
biogen’s
biopharmaceutical
clear
companies
convo
cost
dollar
drug
earlier
easier
eligible
failures
founder
gleason
gleason’s
globally
industry
inner
katelyn
know
largely
littered
lucrative
make
medical
months
murky
nash
new
news
plan
possibly
potentially
price
pulling
Language
Current search:
road
×
startups
×
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@techcrunch.com
7 years ago
Eligible founder Katelyn Gleason’s plan to upend the billion dollar medical billing industry
